Related Experiment Video
Updated: Mar 17, 2026

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Secreted protein kinases regulate cyst burden during chronic toxoplasmosis
Nathaniel G Jones1, Qiuling Wang1, L David Sibley1
1Department of Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Abstract:
Toxoplasma gondii is an apicomplexan parasite that secretes a large number of protein kinases and pseudokinases from its rhoptry organelles. Although some rhoptry kinases (ROPKs) act as virulence factors, many remain uncharacterized. In this study, predicted ROPKs were assessed for bradyzoite expression then prioritized for a reverse genetic analysis in the type II strain Pru that is amenable to targeted disruption. Using CRISPR/Cas9, we engineered C-terminally epitope tagged ROP21 and ROP27 and demonstrated their localization to the parasitophorous vacuole and cyst matrix. ROP21 and ROP27 were not secreted from microneme, rhoptry, or dense granule organelles, but rather were located in small vesicles consistent with a constitutive pathway. Using CRISPR/Cas9, the genes for ROP21, ROP27, ROP28, and ROP30 were deleted individually and in combination, and the mutant parasites were assessed for growth and their ability to form tissue cysts in mice. All knockouts lines were normal for in vitro growth and bradyzoite differentiation, but a combined ∆rop21/∆rop17 knockout led to a 50% reduction in cyst burden in vivo. Our findings question the existing annotation of ROPKs based solely on bioinformatic techniques and yet highlight the importance of secreted kinases in determining the severity of chronic toxoplasmosis.
Insights
Toxoplasma gondii rhoptry kinases (ROPKs) were studied for their role in infection. A combined knockout of ROP21 and ROP17 significantly reduced tissue cyst burden in mice, highlighting their importance in chronic toxoplasmosis.
Area of Science:
- Parasitology
- Molecular Biology
- Infectious Diseases
Background:
- Toxoplasma gondii, an apicomplexan parasite, secretes numerous rhoptry kinases (ROPKs) and pseudokinases.
- While some ROPKs are known virulence factors, many remain uncharacterized, necessitating further investigation into their functions.
Purpose of the Study:
- To characterize unannotated rhoptry kinases (ROPs) in Toxoplasma gondii.
- To investigate the in vivo role of specific ROPKs in parasite virulence and cyst formation.
Main Methods:
- Predicted ROPKs were assessed for bradyzoite expression and prioritized for reverse genetic analysis.
- CRISPR/Cas9 technology was employed to engineer epitope-tagged ROP21 and ROP27 and to generate knockout parasite lines (ROP21, ROP27, ROP28, ROP30).
- Localization studies and in vitro/in vivo assessments of parasite growth, bradyzoite differentiation, and tissue cyst burden in mice were performed.
Main Results:
- ROP21 and ROP27 were localized to the parasitophorous vacuole and cyst matrix, secreted via a constitutive pathway.
- Individual gene knockouts did not affect in vitro growth or bradyzoite differentiation.
- A combined knockout of ROP21 and ROP17 (∆rop21/∆rop17) resulted in a 50% reduction in tissue cyst burden in vivo.
Conclusions:
- The study challenges existing ROPK annotations based solely on bioinformatics.
- Secreted kinases play a crucial role in determining the severity of chronic toxoplasmosis.
- ROP21 and ROP17 are important for maintaining parasite burden in vivo.
More Related Videos
11:21Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
Published on: March 12, 2015
09:52Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii
Published on: July 12, 2013
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Lysosomal Hydrolases